BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26636537)

  • 21. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
    Shlapatska LM; Berdova GG; Kovalevska LM; Kulyk GI; Klein G; Sidorenko SP; Chekhun VF
    Exp Oncol; 2004 Sep; 26(3):210-6. PubMed ID: 15494689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
    Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
    Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells.
    Chen X; Zhao Y; Luo W; Chen S; Lin F; Zhang X; Fan S; Shen X; Wang Y; Liang G
    Theranostics; 2020; 10(22):10290-10308. PubMed ID: 32929349
    [No Abstract]   [Full Text] [Related]  

  • 24. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF; Zhang GD; Huang YQ; Diao Y
    Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin as a modulator of apoptosis in B-lymphoma cells.
    Paternoster L; Radogna F; Accorsi A; Cristina Albertini M; Gualandi G; Ghibelli L
    Ann N Y Acad Sci; 2009 Aug; 1171():345-9. PubMed ID: 19723074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects.
    Ye Q; Zhang Y; Cao Y; Wang X; Guo Y; Chen J; Horn J; Ponomareva LV; Chaiswing L; Shaaban KA; Wei Q; Anderson BD; St Clair DK; Zhu H; Leggas M; Thorson JS; She QB
    Cell Chem Biol; 2019 Mar; 26(3):366-377.e12. PubMed ID: 30661989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of H7 as a novel peroxiredoxin I inhibitor to induce differentiation of leukemia cells.
    Wei W; Ma C; Cao Y; Yang L; Huang Z; Qin D; Chen Y; Liu C; Xia L; Wang T; Lei H; Yu Y; Huang M; Tong Y; Xu H; Gao F; Zhang J; Wu YL
    Oncotarget; 2016 Jan; 7(4):3873-83. PubMed ID: 26716647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxiredoxin 1 - an antioxidant enzyme in cancer.
    Ding C; Fan X; Wu G
    J Cell Mol Med; 2017 Jan; 21(1):193-202. PubMed ID: 27653015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
    Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
    Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression.
    Ismail T; Kim Y; Lee H; Lee DS; Lee HS
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway.
    Jin Y; Yang Q; Liang L; Ding L; Liang Y; Zhang D; Wu B; Yang T; Liu H; Huang T; Shen H; Tu H; Pan Y; Wei Y; Yang Y; Zhou F
    J Exp Clin Cancer Res; 2018 Nov; 37(1):277. PubMed ID: 30454068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
    Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
    Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.
    Siernicka M; Winiarska M; Bajor M; Firczuk M; Muchowicz A; Bobrowicz M; Fauriat C; Golab J; Olive D; Zagozdzon R
    Immunology; 2015 Sep; 146(1):173-83. PubMed ID: 26094816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxiredoxin 1 (Prx1) is a dual-function enzyme by possessing Cys-independent catalase-like activity.
    Sun CC; Dong WR; Shao T; Li JY; Zhao J; Nie L; Xiang LX; Zhu G; Shao JZ
    Biochem J; 2017 Apr; 474(8):1373-1394. PubMed ID: 28219939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ainsliadimer A induces ROS-mediated apoptosis in colorectal cancer cells via directly targeting peroxiredoxin 1 and 2.
    Lv C; Huang Y; Wang Q; Wang C; Hu H; Zhang H; Lu D; Jiang H; Shen R; Zhang W; Liu S
    Cell Chem Biol; 2023 Mar; 30(3):295-307.e5. PubMed ID: 36889312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic effect of icaritin and its mechanisms in inducing apoptosis in human burkitt lymphoma cell line.
    Li ZJ; Yao C; Liu SF; Chen L; Xi YM; Zhang W; Zhang GS
    Biomed Res Int; 2014; 2014():391512. PubMed ID: 24895574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
    Curnock AP; Knox KA
    Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A modified version of galectin-9 induces cell cycle arrest and apoptosis of Burkitt and Hodgkin lymphoma cells.
    Makishi S; Okudaira T; Ishikawa C; Sawada S; Watanabe T; Hirashima M; Sunakawa H; Mori N
    Br J Haematol; 2008 Aug; 142(4):583-94. PubMed ID: 18503581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective Killing of Cancer Cells Through ROS-Mediated Mechanisms by AMRI-59 Targeting Peroxiredoxin I.
    Yang YJ; Baek JY; Goo J; Shin Y; Park JK; Jang JY; Wang SB; Jeong W; Lee HJ; Um HD; Lee SK; Choi Y; Rhee SG; Chang TS
    Antioxid Redox Signal; 2016 Mar; 24(8):453-69. PubMed ID: 26528922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.